AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27389435
Drug: Short-6 mm
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-6 mm implant
Trial: 27389435
Drug: Short-8 mm
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-8 mm implant with OSFE
Trial: 27389435
Drug: Standard-10 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-10 mm implant with OSFE
Trial: 25445508
Drug: Too Good
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Too Good for Drugs (TGFD) prevention program
Trial: 16776793
Drug: Drug-specific computerized
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-specific computerized prescribing alerts (baseline)
Trial: 14687170
Drug: OAF (Omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAF (Omeprazole 20 mg b.d., Amoxicillin 1000 mg b.d., Furazolidone 100 mg b.d. for 14 days)
Trial: 14687170
Drug: OABF1 (Omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OABF1 (Omeprazole 20 mg b.d., Amoxicillin 1000 mg b.d., Furazolidone 100 mg b.d., Bismuth Subcitrate 240 mg b.d. for 14 days)
Trial: 14687170
Drug: OABF2 (Omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OABF2 (Omeprazole 20 mg b.d., Amoxicillin 1000 mg b.d., Furazolidone 200 mg b.d., Bismuth Subcitrate 240 mg b.d. for 14 days)
Trial: 25858519
Drug: Long-term omeprazole
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term omeprazole therapy
Trial: 8951940
Drug: Subcutaneous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous morphine administration
Trial: 8375123
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine administration
Trial: 8404995
Drug: Sodium lactate
RxNorm normalized name: Sodium Lactate
DrugBank: Lactic acid (DB04398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium lactate infusion at rates of 6 to 40 mumol kg‐1 min‐1
Trial: 22309432
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate infusion (control)
Trial: 8404995
Drug: Overall rates
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall rates of lactate appearance during lactate infusions
Trial: 27348913
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group with tramadol sustained release tablets and amitriptyline, prescribed once a day for 4 weeks.
Trial: 22687580
Drug: SAMe 800-1600
RxNorm normalized name: SAMe
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAMe 800-1600 mg/d for 6 weeks
Trial: 15764352
Drug: Legs covered
RxNorm normalized name: Canker Cover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Legs covered with towels during DHT (24 treatments)
Trial: 15764352
Drug: Legs not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Legs not covered with towels during DHT (27 treatments)
Trial: 12062853
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of metformin
Trial: 9458021
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 1.5 g twice daily with intravenous corticosteroids (5 mg/kg/day for 5 days followed by oral taper)
Trial: 9458021
Drug: Azathioprine (AZA)
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine (AZA) 1-2 mg/kg/day with intravenous corticosteroids (5 mg/kg/day for 5 days followed by oral taper)
Trial: 8574509
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of hymecromone
Trial: 25422883
Drug: CP-601,927 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-601,927 2 mg twice daily
Trial: 23312429
Drug: Naltrexone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone with MBSCT and enhanced medication management
Trial: 23312429
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with MBSCT and enhanced medication management
Trial: 23312429
Drug: Naltrexone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone with enhanced medication management only
Trial: 23312429
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with enhanced medication management only
Trial: 15306152
Drug: Monoclonal antiphospholipid
RxNorm normalized name: Egg Phospholipids
DrugBank: Egg phospholipids (DB14233)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antiphospholipid antibodies
Trial: 15306152
Drug: Human sera
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human sera containing antiphospholipid antibodies
Trial: 8431313
Drug: i.v. morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. morphine
Trial: 23419803
Drug: Contact lens
RxNorm normalized name: contact lens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contact lens treatment
Trial: 27183095
Drug: Brentuximab vedotin
RxNorm normalized name: Brentuximab Vedotin
DrugBank: Brentuximab vedotin (DB08870)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brentuximab vedotin (BV) with donor lymphocyte infusion (DLI)
Trial: 27183095
Drug: Brentuximab vedotin
RxNorm normalized name: Brentuximab Vedotin
DrugBank: Brentuximab vedotin (DB08870)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brentuximab vedotin (BV) without donor lymphocyte infusion (DLI)
Trial: 20444845
Drug: Immediate zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Immediate zoledronic acid (ZOL; 4 mg every 6 months)
Trial: 17880755
Drug: Ciprofloxacin 400
RxNorm normalized name: ciprofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days
Trial: 15270876
Drug: Temozolomide 150
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide 150 mg m(‐2) on days 1‐5 every 28 days + IFN‐alpha 2b 10 MIU m(‐2) every other day (Group A)
Trial: 15270876
Drug: Temozolomide 150
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide 150 mg m(‐2) on days 1‐5 every 28 days + IFN‐alpha 2b fixed dose of 10 MIU every other day (Group B)
Trial: 15270876
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who completed at least three cycles of therapy with partial or complete response
Trial: 15270876
Drug: Major side
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Major side effects of treatment
Trial: 11359431
Drug: Budesonide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (400 microg inhaled plus 200 microg intranasal)
Trial: 11359431
Drug: Montelukast (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (10 mg oral)
Trial: 7954251
Drug: Glutamine-supplemented TPN
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine-supplemented TPN (40 g L-alanyl-L-glutamine, 26 g glutamine)
Trial: 29211298
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (3 courses)
Trial: 23385035
Drug: IV rocuronium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV rocuronium 0.06 mg/kg
Trial: 23602668
Drug: MEDI-534 vaccine
RxNorm normalized name: Medi-Lyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI-534 vaccine
Trial: 8635377
Drug: Albuterol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (400 microg every 10 min)
Trial: 8635377
Drug: Albuterol (ED50F)
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (ED50F)
Trial: 8635377
Drug: Albuterol and
RxNorm normalized name: Albuterol and cromolyn only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol and Fenoterol (Heart Rate)
Trial: 30791125
Drug: Levonorgestrel (LNG)
RxNorm normalized name: Levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levonorgestrel (LNG) 40 μg/day
Trial: 30791125
Drug: Anastrozole (ATZ)
RxNorm normalized name: Anastrozole
DrugBank: Anastrozole (DB01217)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anastrozole (ATZ) 300 μg/day
Trial: 29036427
Drug: Combined enalapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined enalapril 10 mg and folic acid 0.8 mg tablet
Trial: 29036427
Drug: Enalapril 10 mg
RxNorm normalized name: enalapril 10 MG
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg tablet alone
Trial: 26871238
Drug: Morphine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (5 mg 0.5% hyperbaric bupivacaine + 0.1 mg morphine)
Trial: 26871238
Drug: Fentanyl (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (5 mg 0.5% hyperbaric bupivacaine + 25 µg fentanyl)
Trial: 26871238
Drug: Control (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (5 mg 0.5% hyperbaric bupivacaine + physiologic saline)
Trial: 23095095
Drug: Standard wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard wound care therapies
Trial: 21060072
Drug: Ticagrelor 180-mg
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor 180-mg loading dose followed by 90 mg twice daily
Trial: 21060072
Drug: Clopidogrel 300-mg
RxNorm normalized name: clopidogrel 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 300-mg loading dose followed by 75 mg daily
Trial: 17425224
Drug: Gaboxadol 5
RxNorm normalized name: Gaboxadol
DrugBank: Gaboxadol (DB06554)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gaboxadol 5 mg
Trial: 8615705
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment with lovastatin
Trial: 1307655
Drug: Low-dose antacids
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose antacids (Alugastrin and Alumag)
Trial: 1307655
Drug: Low-dose antacids
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose antacids and ranitidine
Trial: 162669
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg t.i.d.
Trial: 30985644
Drug: Trichlormethiazide 1
RxNorm normalized name: trichlormethiazide 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trichlormethiazide 1 mg
Trial: 20122589
Drug: Mapleson A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mapleson A system at 10 L/min
Trial: 20122589
Drug: Mapleson D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mapleson D system at 10 L/min
Trial: 20122589
Drug: Circle anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Circle anesthesia system at 10 L/min
Trial: 20122589
Drug: Mapleson A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mapleson A system at 5 L/min
Trial: 20122589
Drug: Mapleson D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mapleson D system at 5 L/min
Trial: 20122589
Drug: Circle anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Circle anesthesia system at 5 L/min
Trial: 17316865
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) spray
Trial: 17316865
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) spray after crossover
Trial: 1479161
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg daily (doubled dose after 4 weeks)
Trial: 1479161
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg twice daily (doubled dose after 4 weeks)
Trial: 1479161
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg twice daily (for refractory patients)
Trial: 6464812
Drug: Assertion training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assertion training treatment
Trial: 30612858
Drug: Cligosiban 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cligosiban 100 mg once daily for 10 days
Trial: 30612858
Drug: Cligosiban 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cligosiban 400 mg once daily for 10 days
Trial: 30612858
Drug: Cligosiban 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cligosiban 800 mg once daily for 10 days
Trial: 30612858
Drug: Cligosiban 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cligosiban 1200 mg once daily for 10 days
Trial: 30612858
Drug: Cligosiban 2400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cligosiban 2400 mg once daily for 10 days
Trial: 24220616
Drug: Decitabine 20
RxNorm normalized name: Decitabine
DrugBank: Decitabine (DB01262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Decitabine 20 mg/m² once daily for 5 days every 4 weeks (n = 242)
Trial: 24220616
Drug: Treatment choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment choice (supportive care or cytarabine 20 mg/m² once daily for 10 days every 4 weeks; n = 243)
Trial: 15641866
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg mirtazapine
Trial: 16183813
Drug: Protein intake
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein intake of 3.3 g/100 kcal
Trial: 16183813
Drug: Protein intake
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein intake of 3.0 g/100 kcal
Trial: 16183813
Drug: Protein intake
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein intake of 2.7 g/100 kcal
Trial: 16183813
Drug: Protein intake
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein intake greater than 2.7 g/100 kcal
Trial: 12562576
Drug: Olanzapine +
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine + Reboxetine (4 mg/day)
Trial: 31809349
Drug: Nanosecond Pulsed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nanosecond Pulsed Electric Field Treatment (NPS)
Trial: 26560511
Drug: THC (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC (0.75 mg twice daily in blocks 1-3 and 1.5 mg twice daily in blocks 4-6)
Trial: 21831581
Drug: Intra-articular multimodal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular multimodal drug injection
Trial: 20141383
Drug: Recreation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recreation therapy
Trial: 17047021
Drug: T3 infusion
RxNorm normalized name: T3
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: T3 infusion
Trial: 16398435
Drug: Local thermotherapy
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local thermotherapy with rabdosia liquid, starting from 1-2 months after operation, once tri-monthly for one year.
Trial: 16398435
Drug: Intravesical perfusion
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical perfusion of mitomycin C, starting from 2 weeks after operation, once weekly for six times, thereafter once monthly for one year.
Trial: 12196768
Drug: Dye-spray (0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dye-spray (0.1% indigo carmine used to coat the entire colon during withdrawal from the cecum)
Trial: 2760254
Drug: Dilevalol (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol (single dose)
Trial: 2760254
Drug: Dilevalol (chronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol (chronic treatment)
Trial: 23715873
Drug: Thiamine supplementation
RxNorm normalized name: thiamine
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiamine supplementation (3 × 100 mg/day for 6 weeks)
Trial: 20415525
Drug: Subcutaneous local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous local anesthesia (LA)
Trial: 20415525
Drug: Intravenous regional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous regional anesthesia (IVRA)
Trial: 19672237
Drug: Galantamine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (8 mg daily for the 1st month, increasing to 16 mg daily; 6 patients received 24 mg from the 3rd month)
Trial: 19672237
Drug: Galantamine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine with antipsychotic therapy (15 patients)
Trial: 10691900
Drug: Oral challenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral challenge with food rich in pseudoallergens
Trial: 17094774
Drug: Sodium phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium phosphate solution
Trial: 2869210
Drug: Synthetic peptide
RxNorm normalized name: Copolymer I (synthetic peptide)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic peptide vaccine (18-aminoacid E. coli heat-stable toxin and 26-aminoacid heat-labile toxin B subunit)
Trial: 2869210
Drug: Synthetic peptide
RxNorm normalized name: Copolymer I (synthetic peptide)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic peptide vaccine
Trial: 30975047
Drug: Telehealth care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telehealth care solution (Telekit)
Trial: 24114969
Drug: Fluticasone propionate/salmeterol
RxNorm normalized name: fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate/salmeterol (FP/SAL) 500/50 μg twice daily
Trial: 22422352
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration (tablet)
Trial: 22422352
Drug: Subcutaneous administration
RxNorm normalized name: subcutaneous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous administration (injection)
Trial: 19744283
Drug: ab initio
RxNorm normalized name: Crotalidae immune F(ab')2 Injection [Anavip]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ab initio calcineurin inhibitor-based monotherapy immunosuppression
Trial: 12117082
Drug: Loteprednol etabonate
RxNorm normalized name: Loteprednol Etabonate
DrugBank: Loteprednol etabonate (DB14596)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loteprednol etabonate 0.2% ophthalmic suspension
Trial: 10195537
Drug: 40 mL
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL of mepivacaine 1% with 100 mg of tramadol (Group B)
Trial: 10195537
Drug: 40 mL
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL of mepivacaine 1% (Group A)
Trial: 10195537
Drug: 40 mL
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL of mepivacaine 1% with 2 mL of isotonic sodium chloride solution and 100 mg of tramadol i.v. (Group C)
Trial: 7782256
Drug: Mupirocin calcium
RxNorm normalized name: Mupirocin Calcium
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin calcium ointment, intranasally bid for 5 days
Trial: 7782256
Drug: Mupirocin calcium
RxNorm normalized name: Mupirocin Calcium
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin calcium ointment
Trial: 7416559
Drug: Sublingual food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual food drops (egg, corn, milk, yeast)
Trial: 31994511
Drug: Lurasidone (40,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone (40, 80, 120 or 160 mg/d)
Trial: 29233028
Drug: 50 µg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 µg liothyronine via nasogastric tube after gastric lavage, in the first 6 h of poisoning
Trial: 29233028
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment of AlP poisoning (control group)
Trial: 8839196
Drug: Pamidronate 180
RxNorm normalized name: Pamidronate
DrugBank: Pamidronic acid (DB00282)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pamidronate 180 mg
Trial: 12383144
Drug: Medication improvement
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medication improvement program (usual care with intervention)
Trial: 8909433
Drug: BCAA (L-leucine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA (L-leucine 12 g, L-isoleucine 8 g, L-valine 6.4 g daily)